Navigation Links
Westaim announces 2008 year-end results
Date:2/18/2009

SHAREHOLDERS' EQUITY Current Accounts payable and accrued liabilities $ 6,956 $ 7,018 Accounts payable and accrued liabilities held for sale 2,885 1,443 ------------------------------------------------------------------------- 9,841 8,461 Deferred gain - 218 Provision for site restoration 6,580 6,580 ------------------------------------------------------------------------- 16,421 15,259 ------------------------------------------------------------------------- Non-controlling interest 10,854 11,757 Shareholders' equity Capital stock 426,280 426,262 Contributed surplus 8,718 7,769 Accumulated other comprehensive income (loss) 1,120 (1,779) Deficit (386,116) (375,881) ------------------------------------------------------------------------- 50,002 56,371 ------------------------------------------------------------------------- $ 77,277 $ 83,387 ------------------------------------------------------------------------- ------------------------------------------------------------------------- THE WESTAIM CORPORATION Consolidated Cash Flow Statements (unaudited) ------------------------------------------------------------------------- Three Months Ended Twelve Months Ended December 31
'/>"/>
SOURCE Westaim Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. The Westaim Corporation update on status of short-term investments
2. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. Westaim announces 2007 third quarter results
4. Westaim reduces ABCP exposure
5. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
6. Westaim announces 2007 year-end results
7. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
8. Westaim announces 2008 first quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
10. Westaim announces 2008 second quarter results
11. Westaim announces sale of iFire Technology Ltd. assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a prominent ... prolotherapy treatments to qualifying patients with demonstrated financial need. , “We are thrilled ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Employee Fiduciary, ... will include the general contact information, website, types of plans administered, years in business, ... business listing and have at least one plan with Employee Fiduciary. A search can ...
(Date:7/29/2015)... ... July 29, 2015 , ... TransFlip is an all new dynamic transition ... presets for FCPX, these transitions are easy to apply and modify for any skill-level ... With over 60 preset styles, kinetic flipping panel animations are just a few clicks ...
(Date:7/29/2015)... ... 29, 2015 , ... Toronto native Douglas James Cottrell, Ph.D., ... has been making predictions about the economy, politics, social issues, as well as ... He warns that extreme weather conditions and increased earthquake / volcanic activity will ...
(Date:7/29/2015)... ... July 29, 2015 , ... The Woodlands and Spring Fit Body Boot ... to worthy charitable causes each month. The new system will track each time a ... Check In at each facility, the boot camps will donate 20 cents to a ...
Breaking Medicine News(10 mins):Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
... * concentrated Tylenol(R) Infants, Drops Plus ... * PediaCare(R) ... Consumer,Healthcare, a division of McNeil-PPC, Inc., announced today that the,company is ... used as directed, these medicines are generally,recognized as safe and effective. ...
... 11 ALOKA Co., Ltd., a pioneer in ... of Masanobu Tada as President, and Carlos Faustmann ... AG, the company,s,wholly-owned European headquarters in Zug, Switzerland, ... the Global Marketing of the company as,general manager ...
... Passage of Plan to Give Access to Affordable Health ... week after Cover,All Pennsylvanians, the centerpiece of his "Prescription ... Rendell today held a,town meeting in Erie as part ... will highlight the need to lower health care costs,and ...
... virus (MMTV) - which causes mammary cancer in mice - ... week shows. The study, published in the online open access ... be involved in causing human breast cancer. , The idea ... around for over 50 years. In the 1990s, researchers detected ...
... Avicena Group,Inc. (OTC Bulletin Board: AVGO), a late-stage ... neurodegenerative,disorders, announced today the appointment of its C.E.O., ... of the Company,s,Board of the Directors. Dr. Tsao- ... Board to focus his time on other business,ventures. ...
... 10 HealthShares(TM) Inc., an investment,company with a family ... has approved the transfer of its 19 currently NYSE-listed,HealthShares ... accordance with NYSE Euronext requirement to transfer of all ... expected to be completed prior to,October 31, 2007. The ...
Cached Medicine News:Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 3Health News:ALOKA Appoints New Management in Europe 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 3Health News:Mouse mammary tumor virus can replicate in human cells 2Health News:Avicena Appoints Dr. Belinda Tsao-Nivaggioli as Chairman of the Board of Directors 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4
(Date:7/29/2015)... 2015  Cepheid (Nasdaq: CPHD ) today ... Xpert® Carba-R, with the addition of two newly ... molecular test also detects and differentiates among the ... KPC, NDM, VIM, IMP-1 and OXA-48. ... Superbugs, are a growing and expensive challenge for ...
(Date:7/29/2015)... , July 29, 2015  Efforts to improve ... strategy of pharmaceutical firms in North America ... realization is that an effective working capital management will ... and patent cliffs. Big pharma companies expect to invest ... Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
(Date:7/29/2015)... , July 29, 2015 ... Therapeutic Vaccines Market - Growth, Trends & Forecasts (2015-2020) ... expected to be worth US$ 2.85 billion by the ... being the largest market globally accounting for more ... market for Therapeutic Vaccines is expected to grow at ...
Breaking Medicine Technology:'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 2New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 3
... Incorporated (NASDAQ: SPEXD) -- an innovator in biotechnology ... and providers of technical and regulatory consulting services ... today announced that its drug candidate, SPX-106, achieved ... administered in combination with D-tagatose for nine weeks ...
... June 2, 2011 Biocept, Inc. today reported that ... at the 2011 Annual Meeting of the American Society ... June 3-7. The poster presentation is based on studies ... C ell E nrichment and E xtraction) ...
Cached Medicine Technology:Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions in Serum Triglycerides in Preclinical Testing 2Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions in Serum Triglycerides in Preclinical Testing 3Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs) 2Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs) 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: